AML is a type of cancer that starts inside bone marrow cells which is the site of blood cells formation (red blood cells and white blood cells). The bone marrow when affected with cancer, will function abnormally and increases the number of abnormal blood cells1. As white blood cells will be affected, the patients with AML will have increased risk of having infections including IFI (aspergillosis and candidiasis). IFI is considered one the main causes of morbidity, mortality and economic burden for patients with AML2. IFIs in immunocompromised cases as in AML patients are difficult to diagnose and treat and thus can lead to various
